Literature DB >> 115389

Distribution of gold among plasma fractions in rheumatoid patients undergoing chrysotherapy compared with its distribution in plasma incubated with aurothiomalate in vitro.

C J Danpure, D A Fyfe, J M Gumpel.   

Abstract

The distribution of gold among the globulin, albumin, and unbound fractions of plasma, obtained either from rheumatoid patients receiving long-term aurothiomalate therapy or from samples incubated with aurothiomalate in vitro, has been investigated. In the rheumatoid patients it has been found that, although the majority of the plasma gold is always bound to albumin, the distribution varies cyclically in phase with the dose schedule. An explanation of these phenomena is provided, based on data obtained from the reaction between aurothiomalate and plasma constituents in vitro.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 115389      PMCID: PMC1000373          DOI: 10.1136/ard.38.4.364

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  20 in total

1.  The interaction of aurothiomalate and cysteine.

Authors:  C J Danpure
Journal:  Biochem Pharmacol       Date:  1976-11-01       Impact factor: 5.858

2.  Blood and urine gold levels during chrysotherapy for rheumatoid arthritis.

Authors:  R Billings; R Grahame; V Marks; P J Wood; A Taylor
Journal:  Rheumatol Rehabil       Date:  1975-02

3.  EFFECT OF GOLD THIOMALATE ON PROTEIN DENATURATION.

Authors:  D A GERBER
Journal:  J Pharmacol Exp Ther       Date:  1964-01       Impact factor: 4.030

4.  METABOLISM, TOXICITY AND MANNER OF ACTION OF GOLD COMPOUNDS USED IN THE TREATMENT OF ARTHRITIS. I. HUMAN PLASMA AND SYNOVIAL FLUID CONCENTRATION AND URINARY EXCRETION OF GOLD DURING AND FOLLOWING TREATMENT WITH GOLD SODIUM THIOMALATE, GOLD SODIUM THIOSULFATE, AND COLLOIDAL GOLD SULFIDE.

Authors:  R H Freyberg; W D Block; S Levey
Journal:  J Clin Invest       Date:  1941-07       Impact factor: 14.808

5.  The uptake and subcellular distribution of gold in rat liver cells after in vivo administration of sodium aurothiomalate.

Authors:  K J Lawson; C J Danpure; D A Fye
Journal:  Biochem Pharmacol       Date:  1977-12-15       Impact factor: 5.858

6.  Determination of gold in plasma and plasma fractions by atomic absorption spectrometry and by neutron activation analysis.

Authors:  R J Ward; C J Danpure; D A Fyfe
Journal:  Clin Chim Acta       Date:  1977-11-15       Impact factor: 3.786

7.  Interaction of aurothiomalate and cystine [proceedings].

Authors:  C J Danpure; K J Lawson
Journal:  Biochem Soc Trans       Date:  1977       Impact factor: 5.407

8.  [The transport form of gold in the blood serum following intravenous or intramuscular administration of various gold salts].

Authors:  R Eberl; H Altmann
Journal:  Z Klin Chem Klin Biochem       Date:  1970-01

9.  'Free' plasma gold in rheumatoid patients undergoing chrysotherapy [proceedings].

Authors:  C J Danpure
Journal:  J Physiol       Date:  1977-05       Impact factor: 5.182

10.  Depression of bone marrow colony formation in gold-induced neutropenia.

Authors:  A Howell; J M Gumpel; R W Watts
Journal:  Br Med J       Date:  1975-02-22
View more
  4 in total

1.  Inhibition of lymphocyte activation by gold sodium thiomalate.

Authors:  S J Hopkins; M I Jayson; P Van der Zeil
Journal:  Br J Pharmacol       Date:  1983-06       Impact factor: 8.739

2.  Is local biotransformation the key to understanding the pharmacological activity of salicylates and gold drugs?

Authors:  M W Whitehouse; G G Graham
Journal:  Inflamm Res       Date:  1996-12       Impact factor: 4.575

Review 3.  Clinical pharmacokinetics of slow-acting antirheumatic drugs.

Authors:  S E Tett
Journal:  Clin Pharmacokinet       Date:  1993-11       Impact factor: 6.447

4.  Measurement of 'free' gold in patients receiving disodium aurothiomalate and the association of high free to total gold levels with toxicity.

Authors:  M J Heath
Journal:  Ann Rheum Dis       Date:  1988-01       Impact factor: 19.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.